TUCSON, Ariz., July 10 /PRNewswire/ -- Ventana Medical Systems, Inc.
(Nasdaq: VMSI), today announced that Henry T. Pietraszek resigned from its
Board of Directors after disclosing trading activities in Ventana's common
stock that the Company believes were contrary to its policies. A Company
spokesperson noted that Ventana continues to investigate the trading
activities and intends to recover any profits due to the Company under the
short swing profit rules of the Securities and Exchange Act of 1934.
Ventana develops, manufactures and markets instrument/reagent systems that
automate tissue preparation and slide staining in histology laboratories
worldwide. Ventana's systems are important tools used in the diagnosis and
treatment of cancer and infectious diseases.
For more information on Ventana Medical Systems, Inc. via facsimile at no
additional cost, simply dial 1-800-PRO-INFO and enter the stock symbol "VMSI".
SOURCE Ventana Medical Systems, Inc.
 back to top
CONTACT:
Christopher Gleeson, President and Chief
Executive Officer, of Ventana Medical Systems, Inc.,
520-887-2155; or Analyst, Kathy Brunson, 312-266-7800, or Media
Inquiries, Cindy Martin, 312-266-7800, both of The Financial
Relations Board for Ventana Medical Systems, Inc.
|
